| abstract |
A pharmaceutical composition, for treatment of a hemostatic disorder, comprises a chimeric protein and a pharmaceutically acceptable carrier or excipient, wherein said chimeric protein comprises at least a portion of an immunoglobulin constant region which is an FeRn binding partner, a clotting factor selected from Factor VII, a Factor VII analog, Factor VIIa and a Factor VIIa analog, and optionally at least one linker. |